European Case Law Identifier: | ECLI:EP:BA:1994:T005193.19940608 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 08 June 1994 | ||||||||
Case number: | T 0051/93 | ||||||||
Application number: | 87106858.1 | ||||||||
IPC class: | A61K 37/38 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | B | ||||||||
Download and more information: |
|
||||||||
Title of application: | Subcutaneous administration of human chorionic gonadotrophin | ||||||||
Applicant name: | Serono Pharmazeutische Präparate GmbH | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Second medical use - way of administration Novelty of auxiliary request (yes) Inventive step (yes) - benefit contrary to prior art expectation |
||||||||
Catchwords: |
A different mode of administration for a pharmaceutical can render a medical use claim drafted according to decision G 5/83 novel. |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t930051eu1.html
Date retrieved: 17 May 2021